Testing effectiveness (Phase 2)Study completedNCT02129777What this trial is testingEfficacy and Safety of Namilumab (MT203) for Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 122
Testing effectiveness (Phase 2)Study completedNCT02949388What this trial is testingEfficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Stable Plaque Psoriasis Innovation Pharmaceuticals, Inc. 199
Testing effectiveness (Phase 2)WithdrawnNCT02011269What this trial is testingTSO for Plaque PsoriasisWho this might be right forPlaque Psoriasis Coronado Biosciences, Inc.
Large-scale testing (Phase 3)Study completedNCT00574249What this trial is testingAdalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic TreatmentWho this might be right forChronic Plaque Psoriasis Abbott 730
Large-scale testing (Phase 3)Study completedNCT02326272What this trial is testingEvaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)Who this might be right forPsoriasisPlaque Psoriasis UCB Biopharma S.P.R.L. 227
Post-approval studies (Phase 4)Ended earlyNCT00739882What this trial is testingTRUST Study: Raptiva ® in Hand & Foot PsoriasisWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 76
Testing effectiveness (Phase 2)Study completedNCT00852670What this trial is testingACT-128800 in PsoriasisWho this might be right forPlaque Psoriasis Actelion 66
Testing effectiveness (Phase 2)Study completedNCT00646191What this trial is testingStudy of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 137
Testing effectiveness (Phase 2)Study completedNCT01483924What this trial is testingStudy to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis ApoPharma 60
Testing effectiveness (Phase 2)Study completedNCT01045577What this trial is testingA Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis AB Science 25
Not applicableStudy completedNCT02786186What this trial is testingA Registry of Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Novartis Pharmaceuticals 2,376
Testing effectiveness (Phase 2)Study completedNCT02969018What this trial is testingStudy To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis Pfizer 212
Not applicableStudy completedNCT00769184What this trial is testingCombining Topical Corticosteroid and LCD Treatment for Localized Plaque PsoriasisWho this might be right forPsoriasis NeoStrata Company, Inc. 15
Not applicableStudy completedNCT01320293What this trial is testingCardiovascular Effects in Psoriasis Patients Treated With Adalimumab.Who this might be right forPsoriasis University of North Carolina, Chapel Hill 18
Not applicableStudy completedNCT05959070What this trial is testingAn Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)Who this might be right forPsoriasis AbbVie 154
Large-scale testing (Phase 3)Study completedNCT02714322What this trial is testingMYL-1401A Efficacy and Safety Comparability Study to Humira®Who this might be right forPsoriasisArthritis, Psoriatic Mylan Inc. 294
Testing effectiveness (Phase 2)Study completedNCT01490632What this trial is testingA Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasisSkin DiseasesSkin Diseases, Papulosquamous Eli Lilly and Company 271
Large-scale testing (Phase 3)Study completedNCT01640951What this trial is testing4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type PsoriasisWho this might be right forModerate to Severe Chronic Plaque-Type Psoriasis Novartis Pharmaceuticals 675
Post-approval studies (Phase 4)Study completedNCT05510063What this trial is testingPharmacokinetics, Efficacy, Safety, and Immunogenicity of SB5 Versus Humira in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Samsung Bioepis Co., Ltd. 371
Testing effectiveness (Phase 2)Study completedNCT02905006What this trial is testingStudy to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma S.P.R.L. 250